• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Rybelsus Online Visit Our Pharmacy ↓

Click HERE To Buy Rybelsus Online ↓




  • Rybelsus for Type 2 Diabetes: What You Need to Know

    Introduction to Rybelsus for Type 2 Diabetes


    Rybelsus is a new medication that has been making waves in the treatment of Type 2 Diabetes. This innovative drug offers a unique approach to managing blood sugar levels and has shown promising results in patients who have struggled with traditional medications. With its convenient dosage form and potential benefits over other options, Rybelsus is quickly becoming a popular choice among healthcare providers and individuals living with Type 2 Diabetes. As with any medication, there are potential side effects and precautions to consider, so it is essential for patients to be aware of these factors before starting treatment with Rybelsus.

    In addition to its efficacy in managing blood sugar, Rybelsus also offers a more convenient dosing schedule compared to some other medications. This can be particularly beneficial for individuals who have busy lifestyles or difficulty adhering to strict medication regimens. The simplicity of Rybelsus administration, combined with its proven effectiveness, has led to many success stories among patients who have incorporated it into their diabetes management routine. Hearing firsthand accounts of improved health and quality of life can provide encouragement and motivation for others considering Rybelsus as part of their treatment plan.

    As patients explore their options for managing Type 2 Diabetes, it is important to understand the role that Rybelsus can play in their overall care. Consulting with healthcare providers and discussing the potential benefits and considerations of Rybelsus is a crucial step in making informed decisions about diabetes management. By staying informed about the latest advancements in diabetes treatment, individuals can take proactive steps towards better health and well-being.

    Patient education and awareness are key components of successful diabetes management, and Rybelsus offers a valuable addition to the range of treatment options available. By staying informed and proactive in their care, individuals can work towards better health outcomes and an improved quality of life while living with Type 2 Diabetes.

    Category Information
    Introduction Rybelsus is a new medication for Type 2 Diabetes
    How it Works Rybelsus offers a unique approach to managing blood sugar levels
    Benefits Convenient dosing, potential advantages over other medications
    Side Effects Potential side effects and precautions to consider



    How Rybelsus Works in Managing Blood Sugar



    Rybelsus, a medication commonly prescribed for Type 2 diabetes, works by targeting the incretin system in the body. Specifically, it mimics the effects of GLP-1, a hormone that helps regulate blood sugar levels. By stimulating insulin release and decreasing glucagon production, Rybelsus helps lower blood sugar levels after meals without causing hypoglycemia. This mechanism of action makes Rybelsus a valuable addition to diabetes treatment regimens, especially for individuals who struggle to control their blood sugar through diet and exercise alone. Patients often appreciate the convenience of Rybelsus, as it is taken orally once a day, offering a simple and effective way to manage their condition. Overall, Rybelsus continues to demonstrate its efficacy in helping patients achieve and maintain better blood sugar control.



    Benefits of Rybelsus Compared to Other Medications


    When comparing Rybelsus to other medications for type 2 diabetes, its unique mechanism of action sets it apart from traditional treatment options. Unlike some medications that may lead to weight gain, Rybelsus is associated with potential weight loss, making it an attractive choice for individuals struggling with weight management alongside diabetes. Additionally, Rybelsus offers the convenience of once-daily dosing, simplifying medication regimens and promoting better adherence. This can be especially beneficial for those with busy lifestyles who may find it challenging to keep up with multiple doses throughout the day. Furthermore, the reduced risk of hypoglycemia associated with Rybelsus compared to some other diabetes medications is another significant advantage, providing patients with greater peace of mind in managing their condition.



    Potential Side Effects and Precautions



    Potential Side Effects and Precautions: It's essential to be aware of the potential side effects and necessary precautions when considering treatment with Rybelsus. Common side effects may include gastrointestinal issues such as nausea, diarrhea, and stomach pain. It is important to monitor blood sugar levels closely, as Rybelsus can cause hypoglycemia, especially when taken with other medications that lower blood sugar. Additionally, precautions should be taken if you have a history of pancreatitis or have a family history of medullary thyroid carcinoma. Be sure to discuss any concerns with your healthcare provider before starting Rybelsus treatment.



    Dosage and Administration Guidelines for Rybelsus


    Rybelsus comes in tablet form for oral administration. The usual starting dose is 3 mg once daily, which may be increased to 7 mg or 14 mg based on individual response and tolerability. It should be taken with or without food at the same time each day to maintain consistency in blood sugar control. It's important to swallow the tablet whole without chewing or crushing it. Patients should follow the dosing schedule provided by their healthcare provider to maximize the effectiveness of Rybelsus and minimize the risk of potential side effects. Below is a table outlining the dosage and administration guidelines for Rybelsus:

    Dosage Administration
    3 mg once daily With or without food at the same time each day
    7 mg or 14 mg Adjust based on response and tolerability



    Patient Experiences and Success Stories with Rybelsus


    Patients who have incorporated Rybelsus into their diabetes management routine have reported significant improvements in their overall well-being. Many have shared inspiring success stories of how Rybelsus has helped them better control their blood sugar levels and lead a more active lifestyle. One patient described feeling more energetic and focused throughout the day, attributing it to the stabilizing effects of Rybelsus on their glucose levels. Another individual highlighted the convenience of Rybelsus, emphasizing how its once-daily dosing regimen fits seamlessly into their daily life. Overall, these personal accounts paint a picture of Rybelsus not just as a medication but as a life-changing solution for individuals living with Type 2 diabetes.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.